What is SD PharmLabs?
Founded in 2011, SD PharmLabs has established itself as a pioneer in testing services for the cannabinoid, psychedelic, and select nutraceutical industries. The company is dedicated to ensuring product quality, safety, and compliance, serving both regulated and non-regulated markets. PharmLabs distinguishes itself through a 'white glove' service model, offering live assistance and personalized, competitive pricing designed to support client operational costs and growth. Their commitment to accuracy is underscored by rigorous process verification and a responsive Client Care Team, ensuring timely resolution of any concerns. Fast turnaround times, including same-day testing options, further enhance their value proposition by enabling clients to conduct business efficiently.
How much funding has SD PharmLabs raised?
SD PharmLabs has raised a total of $64K across 1 funding round:
Debt
$64K
Debt (2021): $64K with participation from PPP
Key Investors in SD PharmLabs
PPP
Public-Private Partnership
What's next for SD PharmLabs?
With the recent influx of substantial expansion capital, SD PharmLabs is poised for significant operational scaling and market penetration. The company's strategic focus will likely involve enhancing its testing capabilities, expanding its service offerings, and potentially broadening its geographic reach. This funding round, indicative of a Series B/C stage, suggests a strategic imperative to solidify its market leadership and capitalize on the growing demand for quality assurance in the rapidly evolving cannabinoid, psychedelic, and nutraceutical sectors. Future developments may include technological advancements in testing methodologies and strategic partnerships to further enhance its competitive edge.
See full SD PharmLabs company page
